Evaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation.

NCT01290172 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplant With Clinically Significant Portal Hypertension

Interventions

DRUG: Administration of Somatostatin
DRUG: Administration of placebo

Sponsor

University Hospital, Ghent